AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Daniel Geynisman

Daniel Geynisman

Fox Chase Cancer Center - Philadelphia / United States
Medical and Health Sciences / Urology
AD Scientific Index ID: 4618480
-
person_outline Daniel Geynisman's MOST POPULAR ARTICLES
1-) Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial The Lancet Oncology 22 (4), 525-537, 2021
2-) Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology Journal of the National Comprehensive Cancer Network 17 (12), 1529-1554, 2019
3-) Muscle-invasive urothelial bladder cancer: an update on systemic therapy Therapeutic advances in urology 7 (6), 312-330, 2015
4-) Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011 Journal of Clinical Oncology 33 (19), 2190-2196, 2015
5-) Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study The lancet oncology 20 (4), 581-590, 2019